St. Johns Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $745K | Buy |
30,953
+2,151
| +7% | +$56.3K | 0.28% | 76 |
|
|
2026
Q1 | $809K | Buy |
28,802
+2,229
| +8% | +$59.3K | 0.34% | 71 |
|
|
2025
Q4 | $662K | Buy |
26,573
+580
| +2% | +$14.6K | 0.28% | 77 |
|
|
2025
Q3 | $662K | Sell |
25,993
-884
| -3% | -$21.8K | 0.28% | 76 |
|
|
2025
Q2 | $651K | Buy |
26,877
+1,934
| +8% | +$45.1K | 0.3% | 74 |
|
|
2025
Q1 | $632K | Sell |
24,943
-342
| -1% | -$8.95K | 0.31% | 71 |
|
|
2024
Q4 | $671K | Sell |
25,285
-4,894
| -16% | -$133K | 0.31% | 71 |
|
|
2024
Q3 | $873K | Sell |
30,179
-592
| -2% | -$17.3K | 0.41% | 62 |
|
|
2024
Q2 | $861K | Sell |
30,771
-903
| -3% | -$24.9K | 0.41% | 59 |
|
|
2024
Q1 | $879K | Buy |
31,674
+1,804
| +6% | +$50.1K | 0.42% | 62 |
|
|
2023
Q4 | $860K | Sell |
29,870
-2,188
| -7% | -$66.1K | 0.44% | 58 |
|
|
2023
Q3 | $1.06M | Sell |
32,058
-853
| -3% | -$30.2K | 0.61% | 49 |
|
|
2023
Q2 | $1.21M | Sell |
32,911
-1,564
| -5% | -$60.9K | 0.66% | 46 |
|
|
2023
Q1 | $1.41M | Buy |
34,475
+144
| +0.4% | +$6.22K | 0.82% | 37 |
|
|
2022
Q4 | $1.76M | Sell |
34,331
-759
| -2% | -$36.4K | 1.05% | 26 |
|
|
2022
Q3 | $1.54M | Buy |
35,090
+757
| +2% | +$36.8K | 1.01% | 25 |
|
|
2022
Q2 | $1.8M | Sell |
34,333
-375
| -1% | -$19.1K | 1.14% | 20 |
|
|
2022
Q1 | $1.8M | Buy |
34,708
+2,068
| +6% | +$107K | 0.96% | 27 |
|
|
2021
Q4 | $1.93M | Buy |
32,640
+908
| +3% | +$45K | 0.98% | 29 |
|
|
2021
Q3 | $1.36M | Buy |
31,732
+852
| +3% | +$37.7K | 0.75% | 43 |
|
|
2021
Q2 | $1.21M | Buy |
30,880
+1,286
| +4% | +$50K | 0.66% | 48 |
|
|
2021
Q1 | $1.07M | Buy |
29,594
+1,039
| +4% | +$36.9K | 0.62% | 52 |
|
|
2020
Q4 | $1.05M | Sell |
28,555
-1,946
| -6% | -$71.4K | 0.65% | 49 |
|
|
2020
Q3 | $1.06M | Sell |
30,501
-213
| -0.7% | -$7.47K | 0.72% | 48 |
|
|
2020
Q2 | $953K | Sell |
30,714
-868
| -3% | -$29.5K | 0.7% | 47 |
|
|
2020
Q1 | $978K | Buy |
31,582
+1,119
| +4% | +$38.1K | 0.88% | 40 |
|
|
2019
Q4 | $1.13M | Buy |
30,463
+207
| +0.7% | +$7.37K | 0.79% | 43 |
|
|
2019
Q3 | $1.03M | Buy |
30,256
+203
| +0.7% | +$7.38K | 0.77% | 45 |
|
|
2019
Q2 | $1.24M | Buy |
30,053
+338
| +1% | +$13.4K | 0.92% | 37 |
|
|
2019
Q1 | $1.2M | Sell |
29,715
-70
| -0.2% | -$2.8K | 0.93% | 37 |
|
|
2018
Q4 | $1.23M | Sell |
29,785
-1,002
| -3% | -$41.6K | 1.1% | 31 |
|
|
2018
Q3 | $1.29M | Sell |
30,787
-2,676
| -8% | -$103K | 0.96% | 34 |
|
|
2018
Q2 | $1.15M | Sell |
33,463
-1,966
| -6% | -$67.2K | 0.85% | 38 |
|
|
2018
Q1 | $1.19M | Sell |
35,429
-547
| -2% | -$18.8K | 0.9% | 35 |
|
|
2017
Q4 | $1.24M | Sell |
35,976
-2,172
| -6% | -$74.1K | 0.91% | 31 |
|
|
2017
Q3 | $1.29M | Sell |
38,148
-911
| -2% | -$29.3K | 0.95% | 30 |
|
|
2017
Q2 | $1.25M | Buy |
39,059
+2,283
| +6% | +$72K | 0.94% | 30 |
|
|
2017
Q1 | $1.19M | Sell |
36,776
-538
| -1% | -$17K | 0.95% | 30 |
|
|
2016
Q4 | $1.15M | Sell |
37,314
-821
| -2% | -$25.1K | 0.95% | 31 |
|
|
2016
Q3 | $1.23M | Buy |
38,135
+610
| +2% | +$20.4K | 1.03% | 27 |
|
|
2016
Q2 | $1.25M | Sell |
37,525
-266
| -0.7% | -$8.49K | 1.13% | 24 |
|
|
2016
Q1 | $1.06M | Buy |
37,791
+35
| +0.1% | +$1K | 0.94% | 32 |
|
|
2015
Q4 | $1.16M | Sell |
37,756
-58
| -0.2% | -$1.82K | 1.04% | 24 |
|
|
2015
Q3 | $1.13M | Buy |
37,814
+164
| +0.4% | +$5.26K | 1.06% | 21 |
|
|
2015
Q2 | $1.2M | Buy |
37,650
+546
| +1% | +$17.8K | 1.03% | 23 |
|
|
2015
Q1 | $1.23M | Sell |
37,104
-760
| -2% | -$24.2K | 1.07% | 19 |
|
|
2014
Q4 | $1.12M | Sell |
37,864
-1,102
| -3% | -$31.6K | 0.97% | 29 |
|
|
2014
Q3 | $1.09M | Sell |
38,966
-133
| -0.3% | -$3.73K | 0.96% | 29 |
|
|
2014
Q2 | $1.1M | Buy |
39,099
+337
| +0.9% | +$9.61K | 0.95% | 30 |
|
|
2014
Q1 | $1.18M | Buy |
+38,762
| New | +$1.16M | 1.06% | 23 |
|
Other funds holding PFE
St. Johns Investment Management's PFE Position: Q2 2026 in Review
St. Johns Investment Management increased its Pfizer (PFE) stake by 7.5% in Q2 2026, buying an estimated $56.3K and bringing the position to 30,953 shares worth $745K. The position accounts for 0.28% of the portfolio, ranked #76.
St. Johns Investment Management first reported a position in PFE in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.93M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- St. Johns Investment Management held 30,953 shares of Pfizer worth $745K as of Q2 2026.
- St. Johns Investment Management bought 2,151 Pfizer shares in Q2 2026, an estimated $56.3K.
- Pfizer made up 0.28% of St. Johns Investment Management's portfolio in Q2 2026, its #76 holding.
- St. Johns Investment Management first reported a position in Pfizer in Q1 2014 and has held it in 50 quarters since.
- St. Johns Investment Management's Pfizer position peaked at $1.93M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on St. Johns Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.